These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38753282)

  • 1. Correction: Evaluation of the National Cancer Institute (NCI) Pathway to Independence Award (K99/R00) Program.
    Schmidt M; Boulanger-Espeut C; Liou G; Ma N; Torres S; Cersosimo S; Bogler O; Zahir N
    J Cancer Educ; 2024 May; ():. PubMed ID: 38753282
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the National Cancer Institute (NCI) Pathway to Independence Award (K99/R00) Program.
    Schmidt M; Boulanger-Espeut C; Liou G; Ma N; Torres S; Cersosimo S; Bogler O; Zahir N
    J Cancer Educ; 2024 Mar; ():. PubMed ID: 38499846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathway to Independence Awards (K99/R00): Funding Dynamics and Prediction of Future National Institutes of Health Research Project Funding.
    Gillen KM; Markowitz DM; Long P; Villegas-Estrada A; Anglon G; Chang E; Gupta A
    Acad Med; 2024 Jan; 99(1):70-75. PubMed ID: 37757590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide to assembling a successful K99/R00 application.
    Michaely P; Bielinski SJ; Campbell K; D'Alessio F; Dean D; Earley YF; Paine R; Salama G; Peter I
    J Clin Transl Sci; 2023; 7(1):e215. PubMed ID: 37900348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of NIH K99/R00 Awards and the Career Progression of Awardees.
    Woitowich NC; Hengel SR; Solis C; Vilgalys TP; Babdor J; Tyrrell DJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 37162873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of NIH K99/R00 awards and the career progression of awardees.
    Woitowich NC; Hengel SR; Solis C; Vilgalys TP; Babdor J; Tyrrell DJ
    Elife; 2024 Jan; 12():. PubMed ID: 38240745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Outcomes for the NHLBI K99/R00 Pathway to Independence Program in Relation to Long-Standing Career Development Programs: Implications for Trainees, Mentors, and Institutions.
    Carlson DE; Wang WC; Scott JD
    Circ Res; 2016 Sep; 119(8):904-8. PubMed ID: 27688307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myths and facts about getting an academic faculty position in neuroscience.
    Hsu NS; Rezai-Zadeh KP; Tennekoon MS; Korn SJ
    Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34452920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to obtain a National Heart, Lung, and Blood Institute-sponsored K08 and K99/R00 grant in the current funding climate.
    Houser SR
    Circ Res; 2012 Mar; 110(7):907-9. PubMed ID: 22461360
    [No Abstract]   [Full Text] [Related]  

  • 10. Spotlight on early-career researchers: an interview with Yi Zhu.
    Commun Biol; 2018; 1():208. PubMed ID: 30564743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition Research Funding Trends and Focus Areas at the US National Cancer Institute.
    Trujillo EB; Hays C; Regan K; Ross S; Seifried H
    JNCI Cancer Spectr; 2022 Sep; 6(5):. PubMed ID: 36047955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
    Kibbe MR; Dardik A; Velazquez OC; Conte MS;
    J Vasc Surg; 2015 Apr; 61(4):1050-7. PubMed ID: 25814368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome evaluation of the National Cancer Institute career development awards program.
    Mason JL; Lei M; Faupel-Badger JM; Ginsburg EP; Seger YR; Dijoseph L; Schnell JD; Wiest JS
    J Cancer Educ; 2013 Mar; 28(1):9-17. PubMed ID: 23292841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.
    Koyuncu CF; Lu C; Bera K; Zhang Z; Xu J; Toro P; Corredor G; Chute D; Fu P; Thorstad WL; Faraji F; Bishop JA; Mehrad M; Castro PD; Sikora AG; Thompson LD; Chernock RD; Lang Kuhs KA; Luo J; Sandulache V; Adelstein DJ; Koyfman S; Lewis JS; Madabhushi A
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
    Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
    WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coding ill-defined and unknown cause of death is 13 times more frequent in Denmark than in Finland.
    Ylijoki-Sørensen S; Sajantila A; Lalu K; Bøggild H; Boldsen JL; Boel LW
    Forensic Sci Int; 2014 Nov; 244():289-94. PubMed ID: 25300069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India.
    Olaku O; Zia F; Santana JM; White JD
    Integr Cancer Ther; 2013 Sep; 12(5):385-92. PubMed ID: 23355475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the National Cancer Act on grant support.
    Kalberer JT
    Cancer Res; 1975 Mar; 35(3):472-81. PubMed ID: 1090361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Funding impact of the National Cancer Act and beyond.
    Kalberer JT; Newell GR
    Cancer Res; 1979 Oct; 39(10):4274-84. PubMed ID: 383282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.